Top Track 250

NextPharma is a pharmaceutical contract development and manufacturing organisation, providing a range of services from clinical trials through to packaging, licensing and logistics. The Surrey-based group operates five sites for development and six for manufacturing, in Germany and France. In June, chief executive Peter Burema, 59, led a buyout backed by CapVest Partners, which agreed to acquire the group from Sun European Partners for an undisclosed sum.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyNextPharma Technologies
ActivityPharma/biotech manufacturer
LocationWoking, Surrey
Sales £m122.7
Operating profit £m21.4
Main shareholdersCapVest Partners (>50%), management (<50%)

If applicable:

* supplied by company   † annualised figure   ‡  profit = ebitda